“This groundbreaking FDA medical device designation sets a new standard in the healthcare apparel market and addresses a major unmet need for healthcare worker safety,” said Bill Bold, CEO of Vestagen.
Vestex apparel is designed to protect healthcare workers from exposure to microorganisms from blood, body fluids and other potentially infectious material.
The FDA cleared Vestex scrub tops, pants, skirts and lab coats to reduce the retention of Methicillin-resistant Staphylococcus aureus on the outer layer of the apparel.
The fluid-repellent fabric surface serves to resist bacteria by repelling fluids and reducing microorganisms remaining on the fabric. The antimicrobial agent then further reduces the MRSA that remains on the surface (outer layer) of the apparel.
The apparel’s ability to reduce the retention of MRSA on the fabric surface has not been shown to correlate with the reduction of infections.
More articles on clinical leadership infection control:
Obese hospital patients less likely to die from sepsis, study finds
Viewpoint: Why state-mandated nurse ratios could harm patient safety
Missouri heart attack patients now sent to best-equipped hospital — not always the closest
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.